
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |||
(Address of principal executive offices) | (Zip Code) |
( |
(Registrant’s telephone number, including area code) |
Title of each class | Trading symbol | Name of each exchange on which registered | ||
☒ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
REVENUE | ||||||||
Net commissions and fees | $ | $ | $ | $ | ||||
Fiduciary investment income | ||||||||
Total revenue | $ | $ | $ | $ | ||||
EXPENSES | ||||||||
Compensation and benefits | ||||||||
General and administrative | ||||||||
Amortization | ||||||||
Depreciation | ||||||||
Change in contingent consideration | ( | ( | ||||||
Total operating expenses | $ | $ | $ | $ | ||||
OPERATING INCOME | $ | $ | $ | $ | ||||
Interest expense, net | ||||||||
Income from equity method investments | ( | ( | ( | ( | ||||
Other non-operating loss (income) | ( | ( | ||||||
INCOME BEFORE INCOME TAXES | $ | $ | $ | $ | ||||
Income tax expense (benefit) | ( | ( | ||||||
NET INCOME | $ | $ | $ | $ | ||||
Net income attributable to non-controlling interests, net of tax | ||||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | $ | ||||
NET INCOME PER SHARE OF CLASS A COMMON STOCK: | ||||||||
Basic | $ | $ | $ | $ | ||||
Diluted | $ | $ | $ | $ | ||||
WEIGHTED-AVERAGE SHARES OF CLASS A COMMON STOCK OUTSTANDING: | ||||||||
Basic | ||||||||
Diluted | ||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
NET INCOME | $ | $ | $ | $ | ||||
Net income attributable to non-controlling interests, net of tax | ||||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | $ | ||||
Other comprehensive income (loss), net of tax: | ||||||||
Gain (loss) on interest rate cap | ( | |||||||
Gain on interest rate cap reclassified to earnings | ( | ( | ( | ( | ||||
Foreign currency translation adjustments | ( | |||||||
Change in share of equity method investments’ other comprehensive income (loss) | ( | ( | ||||||
Total other comprehensive income (loss), net of tax | $( | $ | $ | $ | ||||
COMPREHENSIVE INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | $ | ||||
September 30, 2025 | December 31, 2024 | |||
ASSETS | ||||
CURRENT ASSETS | ||||
Cash and cash equivalents | $ | $ | ||
Commissions and fees receivable – net | ||||
Fiduciary cash and receivables | ||||
Prepaid incentives – net | ||||
Other current assets | ||||
Total current assets | $ | $ | ||
NON-CURRENT ASSETS | ||||
Goodwill | ||||
Customer relationships | ||||
Other intangible assets | ||||
Prepaid incentives – net | ||||
Equity method investments | ||||
Property and equipment – net | ||||
Lease right-of-use assets | ||||
Deferred tax assets | ||||
Other non-current assets | ||||
Total non-current assets | $ | $ | ||
TOTAL ASSETS | $ | $ | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
CURRENT LIABILITIES | ||||
Accounts payable and accrued liabilities | $ | $ | ||
Accrued compensation | ||||
Operating lease liabilities | ||||
Tax Receivable Agreement liabilities | ||||
Short-term debt and current portion of long-term debt | ||||
Fiduciary liabilities | ||||
Total current liabilities | $ | $ | ||
NON-CURRENT LIABILITIES | ||||
Accrued compensation | ||||
Operating lease liabilities | ||||
Long-term debt | ||||
Tax Receivable Agreement liabilities | ||||
Deferred tax liabilities | ||||
Other non-current liabilities | ||||
Total non-current liabilities | $ | $ | ||
TOTAL LIABILITIES | $ | $ | ||
STOCKHOLDERS’ EQUITY | ||||
Class A common stock ($ outstanding at September 30, 2025 and December 31, 2024, respectively) | ||||
Class B common stock ($ outstanding at September 30, 2025 and December 31, 2024, respectively) | ||||
Class X common stock ($ shares authorized, | ||||
Preferred stock ($ December 31, 2024) | ||||
Additional paid-in capital | ||||
Retained earnings | ||||
Accumulated other comprehensive income (loss) | ( | |||
Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc. | $ | $ | ||
Non-controlling interests | ||||
Total stockholders’ equity | $ | $ | ||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | $ |
Nine Months Ended September 30, | ||||
2025 | 2024 | |||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||
Net income | $ | $ | ||
Adjustments to reconcile net income to cash flows provided by operating activities: | ||||
Income from equity method investments | ( | ( | ||
Amortization | ||||
Depreciation | ||||
Prepaid and deferred compensation expense | ||||
Non-cash equity-based compensation | ||||
Amortization of deferred debt issuance costs | ||||
Amortization of interest rate cap premium | ||||
Deferred income tax expense (benefit) | ( | |||
Deferred income tax expense from common control reorganization | ||||
Loss on Tax Receivable Agreement | ||||
Changes in operating assets and liabilities, net of acquisitions: | ||||
Commissions and fees receivable – net | ( | |||
Accrued interest liability | ( | |||
Other current and non-current assets | ( | |||
Other current and non-current accrued liabilities | ( | ( | ||
Total cash flows provided by operating activities | $ | $ | ||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||
Business combinations – net of cash acquired and cash held in a fiduciary capacity | ( | ( | ||
Capital expenditures | ( | ( | ||
Equity method investment in VSIC | ( | |||
Asset acquisitions | ( | |||
Total cash flows used in investing activities | $( | $( | ||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||
Proceeds from Senior Secured Notes | ||||
Borrowings on Revolving Credit Facility | ||||
Repayments on Revolving Credit Facility | ( | ( | ||
Debt issuance costs paid | ( | ( | ||
Proceeds from term debt | ||||
Repayment of term debt | ( | ( | ||
Receipt of contingently returnable consideration | ||||
Payment of contingent consideration | ( | |||
Tax distributions to non-controlling LLC Unitholders | ( | ( | ||
Receipt of taxes related to net share settlement of equity awards | ||||
Taxes paid related to net share settlement of equity awards | ( | ( | ||
Class A common stock dividends and Dividend Equivalents paid | ( | ( | ||
Distributions and Declared Distributions paid to non-controlling LLC Unitholders | ( | ( | ||
Payment of accrued return on Ryan Re preferred units | ( | ( | ||
Net change in fiduciary liabilities | ||||
Total cash flows provided by financing activities | $ | $ | ||
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ||||
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY | $( | $( | ||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Beginning balance | ||||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Ending balance | $ | $ | ||
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ||||
Cash and cash equivalents | $ | $ | ||
Cash and cash equivalents held in a fiduciary capacity | ||||
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | $ | $ | ||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2024 | $ | $ | $ | $ | $( | $ | $ | |||||||||||
Net income (loss) | — | — | — | — | — | ( | — | ( | ||||||||||
Issuance of common stock | — | — | — | — | — | — | — | — | ||||||||||
Exchange of LLC equity for common stock | ( | — | — | — | ( | |||||||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | ( | ||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive loss | — | — | — | — | — | — | ( | ( | ( | |||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ( | |||||||||||
Balance at March 31, 2025 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | — | — | — | — | |||||||||||
Forfeiture of common stock | ( | — | — | — | — | — | — | — | — | |||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | ( | — | — | ( | ( | |||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | — | — | — | |||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investments’ other comprehensive income | — | — | — | — | — | — | ||||||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at June 30, 2025 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at June 30, 2025 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | ||||||||||||||||
Forfeiture and retirement of common stock | ( | — | — | — | ( | — | — | ( | ||||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | — | — | — | ( | ( | |||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | — | ( | |||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investments’ other comprehensive income | — | — | — | — | — | — | ||||||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ( | ( | ( | |||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at September 30, 2025 | $ | $ | $ | $ | $ | $ | $ | $— | ||||||||||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2023 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | — | — | — | — | — | ||||||||||
Exchange of LLC equity for common stock | — | ( | — | — | — | ( | ||||||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | — | ( | |||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive income | — | — | — | — | — | — | ||||||||||||
Gain on interest rate cap, net | — | — | — | — | — | — | ||||||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ( | ( | ( | |||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at March 31, 2024 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | — | ||||||||||||||
Exchange of LLC equity for common stock | — | ( | — | — | — | ( | ||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | — | — | — | ( | ( | |||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | — | — | ( | |||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive income | — | — | — | — | — | — | ( | ( | ( | |||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at June 30, 2024 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at June 30, 2024 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | |||||||||||||||
Forfeiture of common stock | ( | — | — | — | — | — | — | — | — | |||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | — | — | — | |||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive income | — | — | — | — | — | — | ( | ( | ( | |||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at September 30, 2024 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Wholesale Brokerage | $ | $ | $ | $ | ||||
Binding Authority | ||||||||
Underwriting Management | ||||||||
Total Net commissions and fees | $ | $ | $ | $ | ||||
Velocity | USQ | 360 | JM Wilson | Total | ||||||
Cash and cash equivalents | $ | $ | $ | $ | $ | |||||
Commissions and fees receivable – net | ||||||||||
Fiduciary cash and receivables | ||||||||||
Goodwill | ||||||||||
Customer relationships1 | ||||||||||
Other intangible assets | ||||||||||
Property and equipment – net | ||||||||||
Lease right-of-use assets | ||||||||||
Other current and non-current assets | ||||||||||
Total assets acquired | $ | $ | $ | $ | $ | |||||
Accounts payable and accrued liabilities | ||||||||||
Accrued compensation | ||||||||||
Fiduciary liabilities | ||||||||||
Operating lease liabilities | ||||||||||
Deferred tax liabilities | ||||||||||
Total liabilities assumed | $ | $ | $ | $ | $ | |||||
Net assets acquired | $ | $ | $ | $ | $ |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Total revenue | $ | $ | $ | $ | ||||
Net income (loss) | ( | ( | ||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Change in contingent consideration | $ | $( | $( | $ | ||||
Interest expense, net | ||||||||
Total | $ | $ | $ | $ | ||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Beginning of period | $ | $ | $ | $ | ||||
Write-offs | ( | ( | ( | ( | ||||
Increase in provision | ||||||||
End of period | $ | $ | $ | $ | ||||
September 30, 2025 | December 31, 2024 | |||
Prepaid expenses | $ | $ | ||
Insurance recoverable | ||||
Interest rate cap | ||||
Other current receivables | ||||
Total Other current assets | $ | $ |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||
2025 | 2024 | 2025 | 2024 | ||||||
Lease costs | |||||||||
Operating lease costs | $ | $ | $ | $ | |||||
Short-term lease costs | |||||||||
Operating lease costs | |||||||||
Sublease income | ( | ( | ( | ( | |||||
Lease costs – net | $ | $ | $ | $ | |||||
Cash paid for amounts included in the measurement of lease liabilities | |||||||||
Operating cash flows for operating leases | $ | $ | |||||||
Non-cash related activities | |||||||||
Right-of-use assets obtained in exchange for new operating lease liabilities | |||||||||
Amortization of right-of-use assets for operating lease activity | |||||||||
Weighted average discount rate (percent) | |||||||||
Operating leases | |||||||||
Weighted average remaining lease term (years) | |||||||||
Operating leases | |||||||||
September 30, 2025 | December 31, 2024 | |||
Term debt | ||||
payments, Adjusted Term SOFR + Adjusted Term SOFR + September 13, 2031 | $ | $ | ||
Senior secured notes | ||||
mature February 1, 2030 | ||||
mature August 1, 2032 | ||||
Revolving debt | ||||
SOFR + up to July 30, 2029 | ||||
Premium financing notes | ||||
Commercial notes, periodic interest and principal payments, expire May 1, 2026 | ||||
Commercial notes, periodic interest and principal payments, expire June 1, 2026 | ||||
Commercial notes, periodic interest and principal payments, expire June 21, 2026 | ||||
Commercial notes, periodic interest and principal payments, expired May 1, 2025 | ||||
Commercial notes, periodic interest and principal payments, expired June 1, 2025 | ||||
Commercial notes, periodic interest and principal payments, expired June 21, 2025 | ||||
Units subject to mandatory redemption | ||||
Total debt | $ | $ | ||
Less: Short-term debt and current portion of long-term debt | ( | ( | ||
Long-term debt | $ | $ |
Nine Months Ended September 30, 2025 | |||||||||
Restricted Stock | Weighted Average Grant Date Fair Value | Restricted Common Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | ( | ( | |||||||
Forfeited | ( | ||||||||
Unvested at end of period | $ | $ | |||||||
Nine Months Ended September 30, 2025 | |||||||||
IPO RSUs | Incentive RSUs | ||||||||
Restricted Stock Units | Weighted Average Grant Date Fair Value | Restricted Stock Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | ( | ( | |||||||
Forfeited | ( | ( | |||||||
Unvested at end of period | $ | $ | |||||||
Nine Months Ended September 30, 2025 | |||||||||
Reload Options1 | Staking Options1 | Incentive Options | Incentive Options Weighted Average Exercise Price | ||||||
Outstanding at beginning of period | $ | ||||||||
Granted | |||||||||
Exercised | ( | ( | |||||||
Forfeited | ( | ( | |||||||
Outstanding at end of period | $ | ||||||||
Aggregate intrinsic value ($ in thousands): | ||
Reload Options outstanding | $ | |
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable | ||
Weighted-average remaining contractual term (in years): | ||
Reload Options outstanding | ||
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable |
Nine Months Ended September 30, 2025 | |||||||||
IPO RLUs | Incentive RLUs | ||||||||
Restricted LLC Units | Weighted Average Grant Date Fair Value | Restricted LLC Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | ( | ( | |||||||
Forfeited | |||||||||
Unvested at end of period | $ | $ | |||||||
Nine Months Ended September 30, 2025 | |||||||||
Reload Class C Incentive Units | Staking Class C Incentive Units | Class C Incentive Units | Class C Incentive Units Weighted Average Participation Threshold | ||||||
Unvested at beginning of period | $ | ||||||||
Granted | |||||||||
Vested | ( | ( | ( | ||||||
Forfeited | |||||||||
Unvested at end of period | $ | ||||||||
Nine Months Ended September 30, 2025 | |||||||||
PSUs | PLUs | ||||||||
Performance Stock Units | Weighted Average Grant Date Fair Value | Performance LLC Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | ( | ||||||||
Unvested at end of period | $ | $ | |||||||
Volatility | ||
Time to maturity (years) | ||
Risk-free rate | ||
RYAN stock price at valuation date | $ |
Amount | Weighted Average Remaining Expense Period (Years) | |||
Restricted Stock | $ | |||
IPO RSUs | ||||
Incentive RSUs | ||||
Reload Options | ||||
Incentive Options | ||||
PSUs | ||||
Restricted Common Units | ||||
IPO RLUs | ||||
Incentive RLUs | ||||
Reload Class C Incentive Units | ||||
Staking Class C Incentive Units | ||||
Class C Incentive Units | ||||
Total unrecognized equity-based compensation expense | $ |
Recognized | Unrecognized | |||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | As of September 30, 2025 | ||||||||
2025 | 2024 | 2025 | 2024 | |||||||
IPO awards | ||||||||||
IPO RSUs and Staking Options | $ | $ | $ | $ | $ | |||||
IPO RLUs and Staking Class C Incentive Units | ||||||||||
Incremental Restricted Stock and Reload Options | ||||||||||
Incremental Restricted Common Units and Reload Class C Incentive Units | ||||||||||
Pre-IPO incentive awards | ||||||||||
Restricted Stock | ||||||||||
Restricted Common Units | ||||||||||
Post-IPO incentive awards | ||||||||||
Incentive RSUs | ||||||||||
Incentive RLUs | ||||||||||
Incentive Options | ||||||||||
Class C Incentive Units | ||||||||||
PSUs | ( | |||||||||
PLUs | ( | ( | ||||||||
Other expense | ||||||||||
Director Stock Grants | ||||||||||
Total equity-based compensation expense | $ | $ | $ | $ | $ | |||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Net income | $ | $ | $ | $ | ||||
Less: Net income attributable to non-controlling interests | ||||||||
Net income attributable to Ryan Specialty Holdings, Inc. | $ | $ | $ | $ | ||||
Numerator: | ||||||||
Net income attributable to Class A common shareholders | $ | $ | $ | $ | ||||
Add (less): Income attributed to substantively vested RSUs | ( | |||||||
Net income attributable to Class A common shareholders – basic | $ | $ | $ | $ | ||||
Add: Income attributed to dilutive shares | ||||||||
Net income attributable to Class A common shareholders – diluted | $ | $ | $ | $ | ||||
Denominator: | ||||||||
Weighted-average shares of Class A common stock outstanding – basic | ||||||||
Add: Dilutive shares | ||||||||
Weighted-average shares of Class A common stock outstanding – diluted | ||||||||
Earnings per share | ||||||||
Earnings per share of Class A common stock – basic | $ | $ | $ | $ | ||||
Earnings per share of Class A common stock – diluted | $ | $ | $ | $ | ||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Conversion of non-controlling interest LLC Common Units1 | ||||||||
Incentive RSUs | ||||||||
Incentive Options | ||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||
Income Statement Caption | 2025 | 2024 | 2025 | 2024 | |||||
Change in the fair value of the Deal-Contingent Forward | General and administrative | $ | $ | $ | $( | ||||
Total impact of derivatives not designated as hedging instruments | $ | $ | $ | $( | |||||
Interest rate cap premium amortization | Interest expense, net | $( | $( | $( | $( | ||||
Amounts reclassified out of other comprehensive income related to the interest rate cap | Interest expense, net | ||||||||
Total impact of derivatives designated as hedging instruments | $ | $ | $ | $ | |||||
Balance Sheet Caption | September 30, 2025 | December 31, 2024 | |||
Interest rate cap | Other current assets | $ | $ |
September 30, 2025 | December 31, 2024 | |||||||||||
Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |||||||
Assets | ||||||||||||
Interest rate cap | $ | $ | $ | $ | $ | $ | ||||||
Contingently returnable consideration | ||||||||||||
Liabilities | ||||||||||||
Contingent consideration | ||||||||||||
Total assets and liabilities measured at fair value | $ | $ | $ | $ | $ | $ | ||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Assets | ||||||||
Balance at beginning of period | $ | $ | $ | $ | ||||
Newly established assets due to acquisitions | ||||||||
Total gains (losses) included in earnings | ( | |||||||
Total gains (losses) included in OCI | ( | |||||||
Settlements | ( | |||||||
Balance at end of period | $ | $ | $ | $ | ||||
Liabilities | ||||||||
Balance at beginning of period | $ | $ | $ | $ | ||||
Newly established liabilities due to acquisitions | ||||||||
Total losses included in earnings | ||||||||
Total losses included in OCI | ||||||||
Settlements | ( | ( | ||||||
Acquisition measurement period adjustments | ( | |||||||
Balance at end of period | $ | $ | $ | $ | ||||
Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | |||||
Balance at December 31, 2024 | $ | $ | $ | $ | ||||
Exchange of LLC Common Units | ||||||||
Accrued interest | ||||||||
Balance at September 30, 2025 | $ | $ | $ | $ |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
(Gain) loss on interest rate cap | $( | $ | $( | $( | ||||
Gain on interest rate cap reclassified to earnings | ||||||||
Foreign currency translation adjustments | ( | ( | ( | |||||
Change in share of equity method investments’ other comprehensive income (loss) | ( | ( | ||||||
Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss)1 | Total | |||||
Balance at December 31, 2024 | $ | $( | $( | $( | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $( | $ | ||||
Less: Non-controlling interests | ( | ( | ||||||
Balance at March 31, 2025 | $ | $ | $( | $ | ||||
Other comprehensive income before reclassifications | ||||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $ | $ | ||||
Less: Non-controlling interests | ( | |||||||
Balance at June 30, 2025 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | ( | ||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $( | $ | $( | ||||
Less: Non-controlling interests | ( | ( | ( | |||||
Balance at September 30, 2025 | $( | $ | $( | $ |
Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss)1 | Total | |||||
Balance at December 31, 2023 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $ | $( | $ | $ | ||||
Less: Non-controlling interests | ( | |||||||
Balance at March 31, 2024 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $( | $( | ||||
Less: Non-controlling interests | ( | ( | ( | |||||
Balance at June 30, 2024 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | ( | ||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $( | $ | ||||
Less: Non-controlling interests | ( | ( | ||||||
Balance at September 30, 2024 | $ | $ | $( | $ |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Net commissions and fees | $ | $ | $ | $ | ||||
Fiduciary investment income | ||||||||
Total revenue | $ | $ | $ | $ | ||||
Compensation-related expense1 | ||||||||
General and administrative expense2 | ||||||||
Other segment items3 | ||||||||
Depreciation and amortization | ||||||||
Change in contingent consideration | ( | ( | ||||||
Interest income | ( | ( | ( | ( | ||||
Interest expense | ||||||||
Income from equity method investments | ( | ( | ( | ( | ||||
Other non-operating loss (income) | ( | ( | ||||||
Income tax expense (benefit) | ( | ( | ||||||
Net income | $ | $ | $ | $ | ||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
United States | $ | $ | $ | $ | ||||
Foreign | ||||||||
Total revenue | $ | $ | $ | $ | ||||
Nine Months Ended September 30, | ||||
2025 | 2024 | |||
Cash paid for: | ||||
Interest, net1 | $ | $ | ||
Income taxes, net of refunds | ||||
Non-cash investing and financing activities: | ||||
Non-controlling interest holders’ tax distributions declared but unpaid | $ | $ | ||
Tax Receivable Agreement liabilities | ||||
Dividend Equivalents and Declared Distributions liabilities | ||||
Contingently returnable consideration | ||||
Contingent consideration liabilities | ||||
Three Months Ended September 30, | Change | Nine Months Ended September 30, | Change | |||||||||||||
(in thousands, except percentages and per share data) | 2025 | 2024 | $ | % | 2025 | 2024 | $ | % | ||||||||
Revenue | ||||||||||||||||
Net commissions and fees | $739,552 | $588,129 | $151,423 | 25.7 % | $2,256,537 | $1,806,264 | $450,273 | 24.9 % | ||||||||
Fiduciary investment income | 15,025 | 16,565 | (1,540) | (9.3) | 43,376 | 45,917 | (2,541) | (5.5) | ||||||||
Total revenue | $754,577 | $604,694 | $149,883 | 24.8 % | $2,299,913 | $1,852,181 | $447,732 | 24.2 % | ||||||||
Expenses | ||||||||||||||||
Compensation and benefits | 440,434 | 393,249 | 47,185 | 12.0 | 1,355,995 | 1,180,825 | 175,170 | 14.8 | ||||||||
General and administrative | 117,589 | 88,684 | 28,905 | 32.6 | 330,698 | 247,518 | 83,180 | 33.6 | ||||||||
Amortization | 70,188 | 39,182 | 31,006 | 79.1 | 204,841 | 97,711 | 107,130 | NM | ||||||||
Depreciation | 3,607 | 2,467 | 1,140 | 46.2 | 9,134 | 6,820 | 2,314 | 33.9 | ||||||||
Change in contingent consideration | 11,968 | (365) | 12,333 | NM | (2,833) | 813 | (3,646) | NM | ||||||||
Total operating expenses | $643,786 | $523,217 | $120,569 | 23.0 % | $1,897,835 | $1,533,687 | $364,148 | 23.7 % | ||||||||
Operating income | $110,791 | $81,477 | $29,314 | 36.0 % | $402,078 | $318,494 | $83,584 | 26.2 % | ||||||||
Interest expense, net | 56,344 | 49,388 | 6,956 | 14.1 | 169,186 | 109,916 | 59,270 | 53.9 | ||||||||
(Income) from equity method investments | (4,957) | (4,182) | (775) | 18.5 | (15,050) | (13,510) | (1,540) | 11.4 | ||||||||
Other non-operating loss (income) | (402) | 16,590 | (16,992) | NM | (636) | 18,575 | (19,211) | NM | ||||||||
Income before income taxes | $59,806 | $19,681 | $40,125 | NM | $248,578 | $203,513 | $45,065 | 22.1 % | ||||||||
Income tax expense (benefit) | (2,797) | (8,962) | 6,165 | (68.8) | 65,659 | 16,155 | 49,504 | NM | ||||||||
Net income | $62,603 | $28,643 | $33,960 | 118.6 % | $182,919 | $187,358 | $(4,439) | (2.4) % | ||||||||
GAAP financial measures | ||||||||||||||||
Total revenue | $754,577 | $604,694 | $149,883 | 24.8 % | $2,299,913 | $1,852,181 | $447,732 | 24.2 % | ||||||||
Net commissions and fees | 739,552 | 588,129 | 151,423 | 25.7 | 2,256,537 | 1,806,264 | 450,273 | 24.9 | ||||||||
Compensation and benefits | 440,434 | 393,249 | 47,185 | 12.0 | 1,355,995 | 1,180,825 | 175,170 | 14.8 | ||||||||
General and administrative | 117,589 | 88,684 | 28,905 | 32.6 | 330,698 | 247,518 | 83,180 | 33.6 | ||||||||
Net income | 62,603 | 28,643 | 33,960 | 118.6 | 182,919 | 187,358 | (4,439) | (2.4) | ||||||||
Compensation and benefits expense ratio (1) | 58.4 % | 65.0 % | 59.0 % | 63.8 % | ||||||||||||
General and administrative expense ratio (2) | 15.6 % | 14.7 % | 14.4 % | 13.4 % | ||||||||||||
Net income margin (3) | 8.3 % | 4.7 % | 8.0 % | 10.1 % | ||||||||||||
Earnings per share (4) | $0.24 | $0.15 | $0.44 | $0.67 | ||||||||||||
Diluted earnings per share (4) | $0.20 | $0.09 | $0.41 | $0.59 | ||||||||||||
Non-GAAP financial measures* | ||||||||||||||||
Organic revenue growth rate | 15.0 % | 11.8 % | 11.4 % | 13.3 % | ||||||||||||
Adjusted compensation and benefits expense | $417,217 | $343,442 | $73,775 | 21.5% | $1,268,059 | $1,057,424 | $210,635 | 19.9% | ||||||||
Adjusted compensation and benefits expense ratio | 55.3 % | 56.8 % | 55.1 % | 57.1 % | ||||||||||||
Adjusted general and administrative expense | $101,827 | $70,991 | $30,836 | 43.4% | $287,414 | $199,583 | $87,831 | 44.0% | ||||||||
Adjusted general and administrative expense ratio | 13.5 % | 11.7 % | 12.5 % | 10.8 % | ||||||||||||
Adjusted EBITDAC | $235,533 | $190,261 | $45,272 | 23.8% | $744,440 | $595,174 | $149,266 | 25.1% | ||||||||
Adjusted EBITDAC margin | 31.2 % | 31.5 % | 32.4 % | 32.1 % | ||||||||||||
Adjusted net income | $131,704 | $113,633 | $18,071 | 15.9% | $424,225 | $369,604 | $54,621 | 14.8% | ||||||||
Adjusted net income margin | 17.5 % | 18.8 % | 18.4 % | 20.0 % | ||||||||||||
Adjusted diluted earnings per share | $0.47 | $0.41 | $0.06 | 14.6% | $1.52 | $1.34 | $0.18 | 13.4% | ||||||||
Three Months Ended September 30, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Wholesale Brokerage | $376,788 | 50.9 % | $346,666 | 58.9 % | $30,122 | 8.7 % | ||||||
Binding Authority | 89,636 | 12.1 | 76,497 | 13.0 | 13,139 | 17.2 | ||||||
Underwriting Management | 273,128 | 37.0 | 164,966 | 28.1 | 108,162 | 65.6 | ||||||
Total Net commissions and fees | $739,552 | $588,129 | $151,423 | 25.7 % | ||||||||
Three Months Ended September 30, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Net commissions and policy fees | $672,942 | 91.0 % | $555,282 | 94.4 % | $117,660 | 21.2 % | ||||||
Supplemental and contingent commissions | 29,782 | 4.0 | 20,455 | 3.5 | 9,327 | 45.6 | ||||||
Loss mitigation and other fees | 36,828 | 5.0 | 12,392 | 2.1 | 24,436 | 197.2 | ||||||
Total Net commissions and fees | $739,552 | $588,129 | $151,423 | 25.7 % | ||||||||
Nine Months Ended September 30, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Wholesale Brokerage | $1,214,741 | 53.8 % | $1,114,240 | 61.7 % | $100,501 | 9.0 % | ||||||
Binding Authority | 286,110 | 12.7 | 245,762 | 13.6 | 40,348 | 16.4 | ||||||
Underwriting Management | 755,686 | 33.5 | 446,262 | 24.7 | 309,424 | 69.3 | ||||||
Total Net commissions and fees | $2,256,537 | $1,806,264 | $450,273 | 24.9 % | ||||||||
Nine Months Ended September 30, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Net commissions and policy fees | $2,083,983 | 92.4 % | $1,706,781 | 94.5 % | $377,202 | 22.1 % | ||||||
Supplemental and contingent commissions | 103,185 | 4.6 | 58,618 | 3.2 | 44,567 | 76.0 | ||||||
Loss mitigation and other fees | 69,369 | 3.0 | 40,865 | 2.3 | 28,504 | 69.8 | ||||||
Total Net commissions and fees | $2,256,537 | $1,806,264 | $450,273 | 24.9 % | ||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | |||
Current period Net commissions and fees revenue | $739,552 | $588,129 | $2,256,537 | $1,806,264 | |||
Less: Current period contingent commissions | (24,310) | (14,842) | (82,164) | (44,741) | |||
Less: Revenue attributable to sold businesses | (65) | — | (354) | — | |||
Net commissions and fees revenue excluding contingent commissions | $715,177 | $573,287 | $2,174,019 | $1,761,523 | |||
Prior period Net commissions and fees revenue | $588,129 | $487,345 | $1,806,264 | $1,507,878 | |||
Less: Prior year contingent commissions | (14,842) | (4,487) | (44,741) | (30,624) | |||
Less: Revenue attributable to sold businesses | (427) | — | (1,548) | — | |||
Prior period Net commissions and fees revenue excluding contingent commissions | $572,860 | $482,858 | $1,759,975 | $1,477,254 | |||
Change in Net commissions and fees revenue excluding contingent commissions | $142,317 | $90,429 | $414,044 | $284,269 | |||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions | (55,650) | (33,416) | (212,249) | (87,690) | |||
Impact of change in foreign exchange rates | (923) | (196) | (1,324) | (521) | |||
Organic revenue growth (Non-GAAP) | $85,744 | $56,817 | $200,471 | $196,058 | |||
Net commissions and fees revenue growth rate (GAAP) | 25.7 % | 20.7 % | 24.9 % | 19.8 % | |||
Less: Impact of contingent commissions (1) | (0.9) | (2.0) | (1.4) | (0.6) | |||
Net commissions and fees revenue excluding contingent commissions growth rate (2) | 24.8 % | 18.7 % | 23.5 % | 19.2 % | |||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions (3) | (9.7) | (6.9) | (12.0) | (5.9) | |||
Impact of change in foreign exchange rates (4) | (0.1) | 0.0 | (0.1) | 0.0 | |||
Organic Revenue Growth Rate (Non-GAAP) | 15.0 % | 11.8 % | 11.4 % | 13.3 % | |||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | ||||
Total revenue | $754,577 | $604,694 | $2,299,913 | $1,852,181 | ||||
Compensation and benefits expense | $440,434 | $393,249 | $1,355,995 | $1,180,825 | ||||
Acquisition-related expense | (3,583) | (3,785) | (8,546) | (5,171) | ||||
Acquisition related long-term incentive compensation | (7,463) | (15,775) | (25,115) | (17,039) | ||||
Restructuring and related expense | — | (5,693) | — | (35,676) | ||||
Amortization and expense related to discontinued prepaid incentives | (981) | (1,095) | (3,287) | (3,851) | ||||
Equity-based compensation (1) | (7,432) | (17,385) | (36,854) | (39,656) | ||||
Initial public offering related expense | (3,758) | (6,074) | (14,134) | (22,008) | ||||
Adjusted compensation and benefits expense (2) | $417,217 | $343,442 | $1,268,059 | $1,057,424 | ||||
Compensation and benefits expense ratio | 58.4 % | 65.0 % | 59.0 % | 63.8 % | ||||
Adjusted compensation and benefits expense ratio | 55.3 % | 56.8 % | 55.1 % | 57.1 % | ||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | ||||
Total revenue | $754,577 | $604,694 | $2,299,913 | $1,852,181 | ||||
General and administrative expense | $117,589 | $88,684 | $330,698 | $247,518 | ||||
Acquisition-related expense | (15,762) | (12,560) | (43,284) | (35,779) | ||||
Restructuring and related expense | — | (5,133) | — | (12,156) | ||||
Adjusted general and administrative expense (1) | $101,827 | $70,991 | $287,414 | $199,583 | ||||
General and administrative expense ratio | 15.6 % | 14.7 % | 14.4 % | 13.4 % | ||||
Adjusted general and administrative expense ratio | 13.5 % | 11.7 % | 12.5 % | 10.8 % | ||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | ||||
Total revenue | $754,577 | $604,694 | $2,299,913 | $1,852,181 | ||||
Net income | $62,603 | $28,643 | $182,919 | $187,358 | ||||
Interest expense, net | 56,344 | 49,388 | 169,186 | 109,916 | ||||
Income tax expense (benefit) | (2,797) | (8,962) | 65,659 | 16,155 | ||||
Depreciation | 3,607 | 2,467 | 9,134 | 6,820 | ||||
Amortization | 70,188 | 39,182 | 204,841 | 97,711 | ||||
Change in contingent consideration | 11,968 | (365) | (2,833) | 813 | ||||
EBITDAC | $201,913 | $110,353 | $628,906 | $418,773 | ||||
Acquisition-related expense | 19,345 | 16,345 | 51,830 | 40,950 | ||||
Acquisition related long-term incentive compensation | 7,463 | 15,775 | 25,115 | 17,039 | ||||
Restructuring and related expense | — | 10,826 | — | 47,832 | ||||
Amortization and expense related to discontinued prepaid incentives | 981 | 1,095 | 3,287 | 3,851 | ||||
Other non-operating loss (income) | (402) | 16,590 | (636) | 18,575 | ||||
Equity-based compensation | 7,432 | 17,385 | 36,854 | 39,656 | ||||
IPO related expenses | 3,758 | 6,074 | 14,134 | 22,008 | ||||
(Income) from equity method investments | (4,957) | (4,182) | (15,050) | (13,510) | ||||
Adjusted EBITDAC | $235,533 | $190,261 | $744,440 | $595,174 | ||||
Net income margin | 8.3 % | 4.7 % | 8.0 % | 10.1 % | ||||
Adjusted EBITDAC margin | 31.2 % | 31.5 % | 32.4 % | 32.1 % | ||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
(in thousands, except percentages) | 2025 | 2024 | 2025 | 2024 | ||||
Total revenue | $754,577 | $604,694 | $2,299,913 | $1,852,181 | ||||
Net income | $62,603 | $28,643 | $182,919 | $187,358 | ||||
Income tax expense (benefit) | (2,797) | (8,962) | 65,659 | 16,155 | ||||
Amortization | 70,188 | 39,182 | 204,841 | 97,711 | ||||
Amortization of deferred debt issuance costs (1) | 2,397 | 15,402 | 7,157 | 21,838 | ||||
Change in contingent consideration | 11,968 | (365) | (2,833) | 813 | ||||
Acquisition-related expense | 19,345 | 16,345 | 51,830 | 40,950 | ||||
Acquisition related long-term incentive compensation | 7,463 | 15,775 | 25,115 | 17,039 | ||||
Restructuring and related expense | — | 10,826 | — | 47,832 | ||||
Amortization and expense related to discontinued prepaid incentives | 981 | 1,095 | 3,287 | 3,851 | ||||
Other non-operating loss (income) | (402) | 16,590 | (636) | 18,575 | ||||
Equity-based compensation | 7,432 | 17,385 | 36,854 | 39,656 | ||||
IPO related expenses | 3,758 | 6,074 | 14,134 | 22,008 | ||||
(Income) from equity method investments | (4,957) | (4,182) | (15,050) | (13,510) | ||||
Adjusted income before income taxes (2) | $177,979 | $153,808 | $573,277 | $500,276 | ||||
Adjusted income tax expense (3) | (46,275) | (40,175) | (149,052) | (130,672) | ||||
Adjusted net income | $131,704 | $113,633 | $424,225 | $369,604 | ||||
Net income margin | 8.3 % | 4.7 % | 8.0 % | 10.1 % | ||||
Adjusted net income margin | 17.5 % | 18.8 % | 18.4 % | 20.0 % | ||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Earnings per share of Class A common stock – diluted | $0.20 | $0.09 | $0.41 | $0.59 | ||||
Less: Net income attributed to dilutive shares and substantively vested RSUs (1) | (0.09) | (0.03) | (0.01) | (0.29) | ||||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 0.12 | 0.05 | 0.27 | 0.39 | ||||
Plus: Adjustments to Adjusted net income (3) | 0.25 | 0.31 | 0.88 | 0.67 | ||||
Plus: Dilutive impact of unvested equity awards (4) | (0.01) | (0.01) | (0.03) | (0.02) | ||||
Adjusted diluted earnings per share | $0.47 | $0.41 | $1.52 | $1.34 | ||||
(Share count in ’000) | ||||||||
Weighted-average shares of Class A common stock outstanding – diluted | 273,462 | 272,686 | 138,090 | 271,283 | ||||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | — | — | 135,644 | — | ||||
Plus: Dilutive impact of unvested equity awards (4) | 5,526 | 3,467 | 5,407 | 4,445 | ||||
Adjusted diluted earnings per share diluted share count | 278,988 | 276,153 | 279,141 | 275,728 | ||||
(in thousands) | Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | ||||
Balance at December 31, 2024 | $253,233 | $83,415 | $99,648 | $436,296 | ||||
Exchange of LLC Common Units | 26,173 | 1,967 | 8,005 | 36,145 | ||||
Accrued interest | — | — | 783 | 783 | ||||
Balance at September 30, 2025 | $279,406 | $85,382 | $108,436 | $473,224 |
Long-term Incentive Compensation Agreements | ||
(in thousands) | September 30, 2025 | |
Current accrued compensation | $10,500 | |
Non-current accrued compensation | 26,562 | |
Total liability | $37,062 | |
Projected future expense | 48,184 | |
Total projected future cash outflows | $85,246 | |
Projected Future Cash Outflows | ||
(in thousands) | ||
2025 | $6,929 | |
2026 | 17,184 | |
2027 | 16,515 | |
2028 | 35,951 | |
Thereafter | $8,667 | |
Contingent Consideration | ||
(in thousands) | September 30, 2025 | |
Current accounts payable and accrued liabilities | $39,214 | |
Other non-current liabilities | 88,435 | |
Total liability | $127,649 | |
Projected future expense | 12,868 | |
Total projected future cash outflows | $140,517 | |
Projected Future Cash Outflows | ||
(in thousands) | ||
2025 | $270 | |
2026 | 42,030 | |
2027 | 85,654 | |
2028 | 6,283 | |
Thereafter | $6,280 | |
(in thousands) | Balance at September 30, 2025 | 100 BPS Increase | 100 BPS Decrease | |||
Cash and cash equivalents | $153,485 | $(1,535) | $1,535 | |||
Term Loan principal outstanding (1) | 1,687,300 | 16,873 | (16,873) | |||
Interest rate cap notional amount (2) | 1,000,000 | (10,000) | 10,000 | |||
Net exposure to Interest expense, net | $5,338 | $(5,338) | ||||
Cash and cash equivalents held in a fiduciary capacity | $1,220,388 | $12,204 | $(12,204) | |||
Net exposure to Fiduciary investment income | $12,204 | $(12,204) | ||||
Impact to Net income | $6,866 | $(6,866) |
Period | Total Number of Shares Purchased 1 | Average Price Paid per Share | ||
July 1 - July 31, 2025 | — | — | ||
August 1 - August 31, 2025 | — | — | ||
September 1 - September 30, 2025 | 276,634 | $51.8384 | ||
Total | 276,634 | $51.8384 |
Exhibit Number | Description | |
3.1 | ||
3.2 | ||
4.1 | ||
4.2 | ||
4.3 | ||
4.4 | ||
4.5 | ||
4.6 | ||
10.1 | ||
10.2 | ||
10.3 | ||
10.4 | ||
10.5 | ||
10.6 | ||
10.7 | ||
10.8 | ||
10.9 | ||
10.10 | ||
10.11 | ||
10.12 | ||
10.13 | ||
10.14 | ||
10.15 | ||
10.16 | ||
10.17 | ||
10.18 | ||
10.19 | ||
19.1 | ||
31.1 | ||
31.2 | ||
32.1* | ||
32.2* | ||
97.1 | ||
101.INS | Inline XBRL (Extensible Business Reporting Language) Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | |
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
RYAN SPECIALTY HOLDINGS, INC. (Registrant) | ||
Date: October 31, 2025 | By: | /s/ Janice M. Hamilton |
Janice M. Hamilton | ||
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | ||